Use of glucagon-like peptide-1 receptor agonists, aka GLP-1s, increased 40-fold between 2017 and 2021, and it’s estimated ...

Merck & Co (MSD) has entered an exclusive global licence agreement with China-based Hansoh Pharma for a preclinical oral ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...

Clinicians frequently reach out to Catherine Varney, DO, asking if it’s safe to prescribe glucagon-like peptide 1 receptor ...

Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

The Maryland program’s spending on both obesity drugs grew 86% year-over-year, Real Chemistry said, the seventh highest in ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Eli Lilly just gave investors several reasons to cheer.

The underperformance persists despite a 22.6% earnings compounded annual growth rate (CAGR) expected between FY20 and FY25F ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...